[Dynamics of postinfarction left ventricular remodeling during long term use of perindopril, amiodarone, and...

Area of Science:

• Cardiology
• Pharmacology
• Internal Medicine

Background:

• Left ventricular dysfunction is a common complication after myocardial infarction.
• Perindopril is an angiotensin-converting enzyme inhibitor used to treat heart failure.
• Combination therapy may offer enhanced benefits in post-myocardial infarction patients.

Purpose of the Study:

• To evaluate the effects of perindopril monotherapy versus combination therapies on cardiac remodeling and function.
• To compare the efficacy of different beta-blockers and amiodarone when combined with perindopril.

Main Methods:

• A study involving 287 patients with reduced left ventricular ejection fraction post-myocardial infarction.
• Patients received perindopril alone or in combination with amiodarone, metoprolol, bisoprolol, carvedilol, or atenolol for one year.
• Echocardiography was used to assess left ventricular remodeling, systolic, and diastolic function.

Main Results:

• Perindopril combined with carvedilol or amiodarone demonstrated superior anti-remodeling effects.
• Carvedilol and metoprolol improved left ventricular systolic function, while amiodarone, metoprolol, bisoprolol, and atenolol impacted diastolic function.
• Combinations with amiodarone or carvedilol led to the most significant improvements in both systolic and diastolic function.

Conclusions:

• Combination therapy with perindopril, particularly with carvedilol or amiodarone, offers significant benefits in managing post-myocardial infarction left ventricular dysfunction.
• The choice of add-on therapy influences the anti-remodeling and functional recovery outcomes.